These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2440273)

  • 1. Basophil sensitivity and reactivity to monoclonal anti-human IgE after in vitro sensitization with human myeloma IgE.
    Weyer A; Guesdon JL; Ougen P; Marchand F; David B
    Agents Actions; 1987 Apr; 20(3-4):210-2. PubMed ID: 2440273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
    MacGlashan DW
    J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule.
    Wantke F; MacGlashan DW; Langdon JM; MacDonald SM
    J Allergy Clin Immunol; 1999 Apr; 103(4):642-8. PubMed ID: 10200014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.
    Macglashan DW; Saini SS
    J Allergy Clin Immunol; 2013 Oct; 132(4):906-11.e1-4. PubMed ID: 23791510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive in vitro sensitization of human basophils with Dermatophagoides farinae specific IgE.
    Weyer A; Ougen P; Dandeu JP; Marchand F; David B
    Agents Actions; 1986 Apr; 18(1-2):178-81. PubMed ID: 2425579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors.
    Budde IK; de Heer PG; Natter S; Mahler V; van der Zee JS; Valenta R; Aalberse RC
    Immunology; 2002 Oct; 107(2):243-51. PubMed ID: 12383204
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kowal K; Bielecki P; DuBuske IV; DuBuske LM
    Allergy Asthma Proc; 2017 May; 38(3):204-215. PubMed ID: 28441991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood basophil releasability: evaluation of histamine release and leukotriene C4 generation.
    Miadonna A; Leggieri E; Tedeschi A; Lorini M; Motta G; Lucci G; Froldi M; Marini A; Zanussi C
    Int Arch Allergy Appl Immunol; 1988; 86(1):42-7. PubMed ID: 2453473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.
    Laffer S; Lupinek C; Rauter I; Kneidinger M; Drescher A; Jordan JH; Krauth MT; Valent P; Kricek F; Spitzauer S; Englund H; Valenta R
    Allergy; 2008 Jun; 63(6):695-702. PubMed ID: 18325077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-human IgE: histamine release capacity and effect on in vitro sensitization of human basophils.
    Weyer A; Demeulemester C; Mazie JC; Peltre G; Marchand F; David B
    Agents Actions; 1987 Apr; 20(3-4):206-9. PubMed ID: 2440272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monoclonal antihuman IgE on recombinant IgE(301-376) inhibition of specific IgE histamine release.
    Glovsky MM; Kebo D; Helm BA; Horvath S; Richards JA; Chretien I; Bencherau J; Gould H
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):203-5. PubMed ID: 2468614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive sensitization of basophil leukocytes from non-atopic adult by plasma from allergic children.
    Nolte H; Stafanger G; Skov PS; Schiøtz PO
    Allergy; 1988 Jan; 43(1):32-8. PubMed ID: 2449829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.
    Pruzansky JJ; Grammer LC; Patterson R; Roberts M
    J Immunol; 1983 Oct; 131(4):1949-53. PubMed ID: 6194222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
    Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
    Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.
    Saini SS; MacGlashan DW; Sterbinsky SA; Togias A; Adelman DC; Lichtenstein LM; Bochner BS
    J Immunol; 1999 May; 162(9):5624-30. PubMed ID: 10228046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brown Norway rat ovalbumin-specific immunoglobulin E antibodies increase the human basophil expression of CD63 marker.
    Bellou A; Saint-Laudy J; Knippels L; Montémont C; Vauthier E; Gerard P; Pellegrom H; Koerkamp EK; Lesesve JF; Guéant JL; Lambert H; Mallié JP
    Scand J Immunol; 2003 Mar; 57(3):271-8. PubMed ID: 12641656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human basophil degranulation triggered by very dilute antiserum against IgE.
    Davenas E; Beauvais F; Amara J; Oberbaum M; Robinzon B; Miadonna A; Tedeschi A; Pomeranz B; Fortner P; Belon P
    Nature; 1988 Jun; 333(6176):816-8. PubMed ID: 2455231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil histamine release decreases during omalizumab therapy in allergic asthmatics.
    Noga O; Hanf G; Kunkel G; Kleine-Tebbe J
    Int Arch Allergy Immunol; 2008; 146(1):66-70. PubMed ID: 18087163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.